$AKRO

Akero Therapeutics Announces Significant Developments in MASH Treatment

$AKRO Akero Therapeutics, Inc. (NASDAQ:AKRO) has made noteworthy progress in addressing metabolic dysfunction-associated steatohepatitis (MASH), a metabolic disease with a…